9931
|
|
|
Phospholipase A2 group VII |
LDL-PLA2, LP-PLA2, PAFAD, PAFAH |
Asthma, Atherosclerosis, Cerebrovascular disorder, Ischemic heart disease, Coronary artery disease, Diabetes mellitus type 2, Hemolytic uremic syndrome, Hypersensitivity, Nephrotic syndrome, Iga nephropathy, Myocardial ischemia, Stroke |
9932
|
|
|
Phospholipase A2 receptor 1 |
CLEC13C, PLA2-R, PLA2G1R, PLA2IR, PLA2R |
|
9933
|
|
|
Phospholipase A2 activating protein |
DOA1, NDMSBA, PLA2P, PLAP |
|
9934
|
|
|
Phospholipase A and acyltransferase 2 |
HRASLS2, PLA1/2-2, PLAAT-2 |
|
9935
|
|
|
Phospholipase A and acyltransferase 3 |
AdPLA, FPLD9, H-REV107, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3, PLA2G16, PLAAT-3 |
|
9936
|
|
|
Phospholipase A and acyltransferase 4 |
HRASLS4, HRSL4, PLA1/2-3, PLAAT-4, RARRES3, RIG1, TIG3 |
|
9937
|
|
|
Placenta enriched 1 |
CT92, OOSP2B, OOSP2L |
|
9938
|
|
|
Placenta associated 8 |
C15, DGIC, PNAS-144, onzin |
|
9939
|
|
|
PLAG1 zinc finger |
PSA, SGPA, SRS4, ZNF912 |
|
9940
|
|
|
PLAG1 like zinc finger 1 |
LOT1, ZAC, ZAC1 |
|